Geron GERN
NASDAQ GERN
$1.17 +0.01 (+1.29%)
As of: Oct 22, 2026 · 10:34 AM EDT

Geron (GERN) EBIT Margin (2010 - 2026)

Updated

Geron (GERN) posted EBIT Margin of -21.74% for Q2 2026, up 3.66 percentage points from -25.40% a year earlier but down 22.04 percentage points from the prior quarter.

Analysis

Geron (GERN) EBIT Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT Margin at Geron was -21.23%, up 22.54 percentage points year-over-year; for FY2025, it was -30.74%, up 163.55 percentage points from FY2024.

  • Annual EBIT Margin shows a five-year change of +30369.66 percentage points (FY2020 to FY2025).
  • In prior years, Geron's EBIT Margin was -194.29% in FY2024 (+81638.62 pp), -81832.91% in FY2023 (-58586.27 pp), -23246.64% in FY2022 (-15062.94 pp) and -8183.70% in FY2021 (+22216.69 pp).
  • Quarterly EBIT Margin has run from a low of -236039.13% in Q4 2023 to a high of 0.30% in Q1 2026 over five years.
  • On a year-over-year basis, EBIT Margin has increased in each of the last ten quarters, with an average year-over-year change of +36414.59 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2024, with a gain of 236005.69 percentage points; the weakest was Q4 2023, with a drop of 195310.00 percentage points.
  • According to Business Quant data, EBIT Margin for the three prior quarters was 0.30% (Q1 2026), -29.27% (Q4 2025) and -29.40% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,164.36 Bn 1,132.95 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 634.54 Bn 553.07 Bn 17.26 Bn 28.21%
3 AbbVie 502.85 Bn 475.96 Bn 12.70 Bn 37.86%
4 Merck 376.50 Bn 330.88 Bn 12.21 Bn -3.52%
5 Novartis Ag 303.65 Bn 267.64 Bn 11.24 Bn 32.97%
6 Astrazeneca 266.62 Bn 240.30 Bn 12.86 Bn 20.57%
7 Amgen 241.17 Bn 196.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.39 Bn 167.59 Bn 6.22 Bn -133.21%
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn 28.37%
10 Geron 787.30 Mn -564.41 Mn - -21.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.74%
Mar 31, 2026 0.30%
Dec 31, 2025 -29.27%
Sep 30, 2025 -29.40%
Jun 30, 2025 -25.40%
Mar 31, 2025 -42.18%
Dec 31, 2024 -33.44%
Sep 30, 2024 -99.80%
Jun 30, 2024 -7,860.88%
Mar 31, 2024 -18,465.13%
Dec 31, 2023 -236,039.13%
Sep 30, 2023 -29,031.71%
Jun 30, 2023 -179,141.38%
Mar 31, 2023 -190,914.29%
Dec 31, 2022 -40,729.13%
Sep 30, 2022 -13,450.51%
Jun 30, 2022 -38,323.29%
Mar 31, 2022 -23,313.01%
Dec 31, 2021 -2,979.04%
Sep 30, 2021 -23,554.13%
API Access

Geron EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=GERN&period=max&api_key=YOUR_API_KEY